For ectodermal dysplasias caused by variants of the gene TP63 (encoding the transcription factor p63), the typical skin and corneal lesions may be amenable to cell therapy using genetically corrected autologous stem cells. This evidence concerns the gene TP63 and ectodermal dysplasia syndrome.